Advertisement

Johnson & Johnson Will Share Clinical Trial Data — Physician’s First Watch

Medical News |
February 3, 2014

Johnson & Johnson Will Share Clinical Trial Data

By Larry Husten

In a major victory for advocates of open access to data from clinical trials, Johnson & Johnson has announced that it will make all its clinical trial data available to outside researchers. The company said that the Yale University Open Data Access (YODA) Project will serve as an independent third party "to review requests from investigators and physicians seeking access to anonymized clinical trials data."

Johnson & Johnson said the program "is the first time any company has collaborated with a completely independent third party to review and make decisions regarding every request for clinical data."

"This is a remarkable action ... that should accelerate the movement of the clinical research enterprise toward more cooperative learning and sharing," said Harlan Krumholz, leader of the YODA Project and Editor-in-Chief of NEJM Journal Watch Cardiology. "By establishing this fair and independent process to release data, Johnson & Johnson has taken a leadership position in this emerging era of open science."

Adapted from CardioExchange

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement